Učitavanje...
Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCS
The COVID-19 pandemic caused by the novel SARS-CoV-2 is more contagious than other coronaviruses and has higher rates of mortality than influenza. As no vaccine or drugs are currently approved to specifically treat COVID-19, identification of effective therapeutics is crucial to treat the afflicted...
Spremljeno u:
| Izdano u: | Res Sq |
|---|---|
| Glavni autori: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Journal Experts
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7336712/ https://ncbi.nlm.nih.gov/pubmed/32702077 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21203/rs.3.rs-25643/v1 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|